These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1466279)

  • 41. Separation of kininogens by gel filtration of plasminogen-free human plasma.
    Briseid K; Korbu A; Johannesen S
    Acta Pharmacol Toxicol (Copenh); 1976; 39(4):401-11. PubMed ID: 135475
    [No Abstract]   [Full Text] [Related]  

  • 42. Kinin release from human LMW-kininogen by the cooperative action of human plasma kallikrein and leukocyte elastase.
    Sato F; Nagasawa S
    Adv Exp Med Biol; 1989; 247A():493-8. PubMed ID: 2603815
    [No Abstract]   [Full Text] [Related]  

  • 43. The kinins. A status report.
    Erdös EG
    Biochem Pharmacol; 1976 Jul; 25(14):1563-9. PubMed ID: 182170
    [No Abstract]   [Full Text] [Related]  

  • 44. [Calpain and calpastatin].
    Murachi T
    Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of cell adhesion by high molecular weight kininogen.
    Asakura S; Hurley RW; Skorstengaard K; Ohkubo I; Mosher DF
    J Cell Biol; 1992 Jan; 116(2):465-76. PubMed ID: 1370494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Properties of chemically oxidized kininogens.
    Nieziołek M; Kot M; Pyka K; Mak P; Kozik A
    Acta Biochim Pol; 2003; 50(3):753-63. PubMed ID: 14515155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased kinin levels and decreased responsiveness to kinins during aging.
    Pérez V; Velarde V; Acuña-Castillo C; Gómez C; Nishimura S; Sabaj V; Walter R; Sierra F
    J Gerontol A Biol Sci Med Sci; 2005 Aug; 60(8):984-90. PubMed ID: 16127100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developments in the design and synthesis of calpain inhibitors.
    Neffe AT; Abell AD
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
    Matsueda R; Umeyama H; Puri RN; Bradford HN; Colman RW
    Pept Res; 1994; 7(1):32-5. PubMed ID: 8019060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural aspects of human kininogens.
    Muller-Esterl W; Dittmann B; Fritz H; Lottspeich F; Henschen A
    Adv Exp Med Biol; 1983; 156():157-64. PubMed ID: 6552837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular regulatory system involving calpain and calpastatin.
    Murachi T
    Biochem Int; 1989 Feb; 18(2):263-94. PubMed ID: 2548504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and location of divalent cation binding sites in bovine glial fibrillary acidic protein.
    Yang ZW; Kong CF; Babitch JA
    Biochemistry; 1988 Sep; 27(18):7045-50. PubMed ID: 3196700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bovine plasma kininogens. II. Microheterogeneities of high molecular weight kininogens and their structural relationships.
    Komiya M; Kato H; Suzuki T
    J Biochem; 1974 Oct; 76(4):823-32. PubMed ID: 4474169
    [No Abstract]   [Full Text] [Related]  

  • 54. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
    Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
    Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The plasma kinin-forming system in labour.
    Malofiejew M
    Clin Sci Mol Med; 1973 Oct; 45(4):429-38. PubMed ID: 4751962
    [No Abstract]   [Full Text] [Related]  

  • 56. [Identification of kinins releasing by pig pancreatic kallikrein from rabbit low molecular weight kininogen].
    Paskhina TS; Makevnina LG; Egorova TP; Levina GO
    Biokhimiia; 1977 Jun; 42(6):1144-7. PubMed ID: 889975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Kallikrein-Kinin system.
    Hillmeister P; Persson PB
    Acta Physiol (Oxf); 2012 Dec; 206(4):215-9. PubMed ID: 23110467
    [No Abstract]   [Full Text] [Related]  

  • 58. Origins of the difference in Ca2+ requirement for activation of mu- and m-calpain.
    Dutt P; Spriggs CN; Davies PL; Jia Z; Elce JS
    Biochem J; 2002 Oct; 367(Pt 1):263-9. PubMed ID: 12014988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteolytic processing of nuclear factor kappa B by calpain in vitro.
    Liu ZQ; Kunimatsu M; Yang JP; Ozaki Y; Sasaki M; Okamoto T
    FEBS Lett; 1996 Apr; 385(1-2):109-13. PubMed ID: 8641452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Ca(2+) switch aligns the active site of calpain.
    Moldoveanu T; Hosfield CM; Lim D; Elce JS; Jia Z; Davies PL
    Cell; 2002 Mar; 108(5):649-60. PubMed ID: 11893336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.